Cancer Treatment

There are over 200 types of cancer known, ranging from skin cancer, lung cancer, and prostate cancer. The symptoms may differ significantly for different kinds of cancer, but they all have one thing in common: Cancer. The Apollo Hospitals Cancer Institute is a symbol of hope for thousands of patients and their families, who come here for treatment every year from over 120 countries, offering complete cancer cure for over 93% of cases.

Definitive Diagnosis and Collaborative Treatment Approach

Cancer demands a combination of treatment including radiation therapy, surgical treatment, and medical management. Apollo Institutes of Cancer offer patients a collaborative approach, accurate diagnosis, and unbiased treatment options. Key milestones of the Apollo Hospitals oncology department include being the first to accomplish Ammonia Myocardial Perfusion Studies in India and the first to offer PET/CT with Onsite Cyclotron. Apollo Hospitals is also the first Indian hospital group to introduce Stereotactic Radiotherapy and Radiosurgery.

Cutting-Edge Technology

The Oncology department features cancer treatments including the Dual Tracer Scans, Biological Therapy, Hypofractionated Radiation Therapy, Chemotherapy, Hormonal Therapy, Immunotherapy, Targeted Therapy, Brachy Therapy and Proton Therapy, leveraging on cutting-edge medical technology: Positron Emission Tomography (PET) scans, CyberKnife and Novalis radiosurgery platforms.

Apollo Hospitals established 9 dedicated cancer care hospitals across India including Apollo Specialty Cancer Hospital, Apollo Cancer Hospitals Hyderabad, Apollo Hospitals Ahmedabad, Apollo Hospitals Bengaluru, and Apollo Gleneagles Cancer Hospital Kolkata, featuring over 125 surgical and radiation cancer specialists.

International patients are welcome to browse through our find a doctor section for online consultation with a physician before planning your medical trip to India. For assistance with medical travel documents and any other inquiries, please feel free to contact our international patient representatives.